Trial Profile
Phase I trial of OCV 105 in patients with treatment-refractory pancreatic cancer in Japan.
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 17 Jun 2011
Price :
$35
*
At a glance
- Drugs OCV 105 (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions
- 17 Jun 2011 New trial record